Rice, Texas Heart Institute scientists model how synthetic gels can tune body’s inflammatory response
Rice researchers and collaborators at Texas Heart Institute (THI) have established a baseline set of injectable hydrogels that promise to help heal wounds, deliver drugs and treat cancer. Critically, they’ve analyzed how the chemically distinct hydrogels provoke the body’s inflammatory response — or not.
Hydrogels developed at Rice are designed to be injectable and create a mimic of cellular scaffolds in a desired location. They serve as placeholders while the body naturally feeds new blood vessels and cells into the scaffold, which degrades over time to leave natural tissue in its place. Hydrogels can also carry chemical or biological prompts that determine the scaffold’s structure or affinity to the surrounding tissue.
The study led by chemist and bioengineer Jeffrey Hartgerink and graduate student Tania Lopez-Silva at Rice and Darren Woodside, vice president for research and director of the flow cytometry and imaging core at THI, demonstrates it should be possible to tune multidomain peptide hydrogels to produce appropriate inflammatory response for what they’re treating.
The research appears in Biomaterials.
“We’ve been working on peptide-based hydrogels for a number of years and have produced about 100 different types,” Hartgerink said. “In this paper, we wanted to back up a bit and understand some of the fundamental ways in which they modify biological environments.”
The researchers wanted to know specifically how synthetic hydrogels influence the environment’s inflammatory response. The two-year study offered the first opportunity to test a variety of biocompatible hydrogels for the levels of inflammatory response they trigger.
“Usually, we think of inflammation as bad,” Hartgerink said. “That’s because inflammation is sometimes associated with pain, and nobody likes pain. But the inflammatory response is also extremely important for wound healing and in clearing infection.
“We don’t want zero inflammation; we want appropriate inflammation,” he said. “If we want to heal wounds, inflammation is good because it starts the process of rebuilding vasculature. It recruits all kinds of cells that are regenerative to that site.
The labs tested four basic hydrogel types — two with positive charge and two negative — to see what kind of inflammation they would trigger. They discovered that positively charged hydrogels triggered a much stronger inflammatory response than negatively charged ones.
“Among the positive materials, depending on the chemistry generating that charge, we can either generate a strong or a moderate inflammatory response,” Hartgerink said. “If you’re going for wound-healing, you really want a moderate response, and we saw that in one of the four materials.
“But if you want to go for a cancer treatment, the higher inflammatory response might be more effective,” he said. “For something like drug delivery, where inflammation is not helpful, one of the negatively charged materials might be better.
“Basically, we’re laying the groundwork to understand how to develop materials around the inflammatory responses these materials provoke. That will give us our best chance of success.”
The THI team helped analyze the cellular response to the hydrogels through multidimensional flow cytometry.
“The results of this work lay the groundwork for specifically tailoring delivery of a therapeutic by a delivery vehicle that is functionally relevant and predictable,” Woodside said. “Aside from delivering drugs, these hydrogels are also compatible with a variety of cell types.
“One of the problems with stem cell therapies at present is that adoptively transferred cells don’t necessarily stay in high numbers at the site of injection,” he said. “Mixing these relatively inert, negatively charged hydrogels with stem cells before injection may overcome this limitation.”
Hartgerink said the work is foundational, rather than geared toward a specific application, but is important to the long-term goal of bringing synthetic hydrogels to the clinic. “We have been speculating about a lot of the things we think are good and true about this material, and we now have more of a sound mechanistic understanding of why they are, in fact, true,” Hartgerink said.
Learn more: Hydrogels control inflammation to help healing
Go deeper with Bing News on:
Hydrogels to control inflammation
- New breakthrough in the treatment of rheumatoid arthritison November 25, 2020 at 9:47 am
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a ...
- Regenerative drug summons stem cells for inflammation-free healingon November 23, 2020 at 4:00 pm
That resulted in extended lifespan, delayed onset of symptoms, better motor function for longer, and reduced inflammation, compared to control mice that didn’t receive the drug. “We are ...
- Anti-Inflammatory Drugs Market to Exhibit 9.3% CAGR by 2027 Owing to Rising Prevalence of Inflammatory Health Conditions: Fortune Business Insights™on November 19, 2020 at 3:50 am
and others are the major anti-inflammatory drugs market growth driver. As per the Centers for Disease Control and Prevention, an estimate of 78 million people in the U.S. will be diagnosed with ...
- 3D-Printed Rubbery Brain Implants Could Replace Rigid Materialson November 17, 2020 at 4:00 pm
While the human brain is made of soft tissue, implants surgeons use to treat brain disorder or injuries are typically made from rigid materials such as metals, which can pose future health risks such ...
- What is the role of hyperbaric oxygen therapy (HBOT) in the treatment of traumatic brain injury?on November 15, 2020 at 4:00 pm
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel ...
Go deeper with Google Headlines on:
Hydrogels to control inflammation
Go deeper with Bing News on:
- Regenerative drug summons stem cells for inflammation-free healingon November 24, 2020 at 6:17 pm
Researchers have developed a drug that can mimic inflammation signals to lure stem cells to damaged tissue, without causing any further inflammation. The technique could be a boon for regenerative ...
- 'Dramatic' Inflammation Reduction After OHCA With Tocilizumabon November 24, 2020 at 10:46 am
A pilot study showed reduced systemic inflammatory response and cardiac injury in out-of-hospital cardiac arrest patients, with the hope of affecting mortality and neurologic outcome in larger trials.
- COVID-19 during pregnancy can cause placental inflammation and impaired immunityon November 19, 2020 at 6:09 pm
A new study conducted by a team of researchers at Johns Hopkins University, USA, has observed how pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show stunted ...
- Two Anti-inflammatory Medications Shown to Accelerate Recovery From COVID-19on November 18, 2020 at 4:40 pm
“Both compounds caused a robust anti-inflammatory response that culminated in a fairly rapid recovery of respiratory function in the patients,” Rodrigo Calado, who led the study at FMRP-USP, told ...
- NeurodigitX Launches First Digital Inflammatory Biomarker Platform to Support COVID-19 Pandemic Exit Strategyon November 18, 2020 at 8:43 am
NeurodigitX, the innovative digital health company, announced today a new comprehensive platform called Plastic Health™ that allows a powerful mainstream bloodless assessment of inflammation levels, ...